A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03)
Conditions
Metastatic Colorectal Cancer
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Illinois CancerCare PC, Peoria, Illinois, United States
Profound Research LLC at Cancer and Leukemia Center, Sterling Heights, Michigan, United States
Missouri Cancer Associates - 150518964, Columbia, Missouri, United States
SCRI Oncology Partners, Nashville, Tennessee, United States
Texas Oncology DFW, Bedford, Texas, United States
Texas Oncology- San Antonio, San Antonio, Texas, United States
GenesisCare North Shore (Oncology), St Leonards, New South Wales, Australia
Icon Cancer Centre Chermside, Chermside, Queensland, Australia
Study leads
Medical Responsible
Study Director
EMD Serono Research & Development Institute, Inc.